Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Veeva Systems (VEEV)

NYSE Health Care Health Care Technology S&P 500
$303.73
-6.37 (-2.05%)
Close of Nov 06, 2026 · end-of-day data
Source: Veeva Systems's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 03, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue$550.54M$690.56M$862.21M$1.10B$1.47B$1.85B$2.16B$2.36B$2.75B$3.20B
Cost of revenue$173.68M$211.44M$245.28M$303.37M$408.93M$503.68M$609.40M$677.29M$699.64M$782.02M
Gross profit$376.86M$479.14M$616.93M$800.71M$1.06B$1.35B$1.55B$1.69B$2.05B$2.41B
Research & development$96.74M$132.02M$158.78M$209.90M$294.22M$382.04M$520.28M$629.03M$693.08M$767.39M
Operating income$120.69M$157.93M$222.87M$286.22M$377.79M$505.50M$459.09M$429.33M$691.43M$916.37M
Pre-tax income$122.36M$165.77M$238.64M$313.70M$393.99M$512.31M$509.10M$588.02M$919.38M$1.19B
Income tax$44.78M$14.59M$8.81M$12.58M$13.99M$84.92M$21.39M$62.32M$205.24M$285.60M
Net income$77.57M$151.18M$229.83M$301.12M$380.00M$427.39M$487.71M$525.71M$714.14M$908.91M
EBITDA$134.51M$172.21M$236.94M$306.08M$386.79M$512.50M$465.09M$435.33M——
EPS (basic)$0.57$1.08$1.59$2.04$2.52$2.79$3.14$3.27$4.41$5.55
EPS (diluted)$0.53$0.98$1.47$1.90$2.36$2.63$3.00$3.22$4.32$5.44
Diluted shares147.58M153.68M156.12M158.30M160.73M162.28M162.44M163.49M165.23M167.00M
Gross margin68.5%69.4%71.6%72.5%72.1%72.8%71.7%71.3%74.5%75.5%
Operating margin21.9%22.9%25.8%25.9%25.8%27.3%21.3%18.2%25.2%28.7%
Net margin14.1%21.9%26.7%27.3%25.9%23.1%22.6%22.2%26.0%28.4%

Balance sheet

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash & equivalents$217.61M$320.18M$550.97M$476.73M$730.50M$1.14B$886.47M$703.49M$1.12B$1.42B
Short-term investments—$441.78M$539.19M$610.01M$933.12M$1.24B$2.22B$3.32B$4.03B$5.14B
Receivables$182.82M$224.67M$303.46M$389.69M$564.39M$631.13M$703.05M$852.17M$1.02B$1.26B
Total current assets$711.87M$1.01B$1.43B$1.53B$2.31B$3.11B$3.97B$5.00B$6.31B$8.00B
Goodwill$95.80M$95.80M$95.80M$438.53M$436.03M$439.88M$439.88M$439.88M$439.88M$439.88M
Total assets$917.38M$1.23B$1.65B$2.27B$3.05B$3.82B$4.80B$5.91B$7.34B$8.98B
Total current liabilities$246.78M$306.17M$401.02M$551.17M$715.95M$840.78M$1.01B$1.18B$1.40B$1.64B
Total liabilities$264.72M$324.10M$416.02M$606.18M$779.75M$904.83M$1.09B$1.27B$1.51B$1.76B
Shareholders' equity$678.15M$906.24M$1.24B$1.67B$2.27B$2.91B$3.72B$4.64B$5.83B$7.21B

Cash flow

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow$144.01M$233.44M$310.83M$437.38M$551.25M$764.46M$780.47M$911.34M$1.09B$1.42B
Capital expenditures$6.92M$9.63M$8.44M$3.11M——————
Free cash flow$137.09M$223.81M$302.39M$434.26M$551.25M$764.46M$780.47M$911.34M$1.09B$1.42B
Investing cash flow-$96.75M-$154.52M-$103.87M-$516.91M-$333.63M-$346.15M-$1.01B-$1.08B-$700.14M-$1.10B
Financing cash flow$37.98M$20.77M$25.91M$10.01M$33.82M-$4.14M-$19.38M-$16.19M$26.11M-$9.33M
Share buybacks———————$0$0$169.95M
Stock-based compensation$40.80M$54.05M$76.42M$115.91M$185.00M$234.64M$351.91M$393.73M$437.35M$472.70M
Depreciation & amortization$13.82M$14.28M$14.07M$19.86M$9.00M$7.00M$6.00M$6.00M——

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.